Traws Pharma, Inc. — Director's Dealing 2020

Jul 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2020-07-09

Reporting Person: Hoffman Michael B (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-09	Stock Appreciation Right	$0.56	A	125000	Acquired	2030-07-09	Common Stock (125000)	Direct

Footnotes

F1: These stock appreciation rights vest 100% on the first anniversary of the grant date.